⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1248824 | 0.72 | — | — | |
| SCHEMBL2610342 | 0.71 | — | — | |
| SCHEMBL246936 | 0.69 | — | — | |
| SCHEMBL9238444 | 0.69 | — | — | |
| SCHEMBL2801364 | 0.69 | — | — | |
| SCHEMBL1723477 | 0.67 | — | — | |
| SCHEMBL82623 | 0.65 | — | — | |
| SCHEMBL7863815 | 0.65 | — | — | |
| SCHEMBL5491486 | 0.65 | — | — | |
| SCHEMBL8373377 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110891590-B | Glycopeptide derivative compound and use thereof | 英斯麦德公司 | 2023-07-18 | — | — | CN | disclosed |
| US-11612598-B2 | Compounds and methods for the treatment of cancer | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-03-28 | — | — | US | disclosed |
| US-20210388028-A1 | GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF | BIOPHARMA CREDIT PLC (GB) | 2021-12-16 | — | — | US | disclosed |
| EP-3883590-A1 | GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF | Insmed Incorporated (US) | 2021-09-29 | — | — | EP | disclosed |
| US-10889849-B2 | Oxidized glutathione assay | PROMEGA CORPORATION (US) | 2021-01-12 | — | — | US | disclosed |
| US-20200368312-A1 | GLYCOPEPTIDE DERIVATIVE COMPOUNDS AND USES THEREOF | INSMED INCORPORATED (US) | 2020-11-26 | — | — | US | disclosed |
| CN-106946812-B | Design, synthesis and evaluation of procaspase activating compounds as personalized anticancer agents | 伊利诺伊大学评议会 | 2020-10-09 | — | — | CN | disclosed |
| WO-2020167566-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOL USE DISORDERS | THE ROCKEFELLER UNIVERSITY (US) | 2020-08-20 | — | — | WO | disclosed |
| US-10745365-B2 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | PROMEGA CORPORATION (US) | 2020-08-18 | — | — | US | disclosed |
| US-10711037-B2 | Chemical and biochemical adducts as biomarkers for organophosphate exposure | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2020-07-14 | — | — | US | disclosed |
| WO-2001098327-A2 | GLYCOPEPTIDE CARBOXY-SACCHARIDE DERIVATIVES | THERAVANCE, INC. (US) | 2001-12-27 | — | — | WO | disclosed |
| WO-2001082971-A2 | CYCLODEXTRIN CONTAINING GLYCOPEPTIDE ANTIBIOTIC COMPOSITIONS | THERAVANCE, INC. (US) | 2001-11-08 | — | — | WO | disclosed |
| WO-2001083520-A2 | POLYACID GLYCOPEPTIDE DERIVATIVES | THERAVANCE,INC (US) | 2001-11-08 | — | — | WO | disclosed |
| WO-2001083521-A2 | REDUCTIVE ALKYLATION PROCESS ON GLYCOPEPTIDES | THERAVANCE, INC. (US) | 2001-11-08 | — | — | WO | disclosed |
| WO-2001080905-A2 | SIGMA-2 RECEPTORS AS BIOMARKERS OF TUMOR CELL PROLIFERATION | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2001-11-01 | — | — | WO | disclosed |
| EP-1140993-A1 | GLYCOPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Advanced Medicine, Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| CN-1315961-A | Glycopeptide derivatives and pharmaceutical compositions containing same | ADVANCED MEDICINE INC (US) | 2001-10-03 | — | — | CN | disclosed |
| WO-2001057071-A2 | GLYCOPEPTIDE DERIVATIVES HAVING ANTIBIOTIC ACTIVITY | ADVANCED MEDICINE, INC. (US) | 2001-08-09 | — | — | WO | disclosed |
| CN-1295558-A | Novel local anesthetic compounds and uses | ADVANCED MEDICINE INC (US) | 2001-05-16 | — | — | CN | disclosed |
| WO-2000039156-A1 | GLYCOPEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | ADVANCED MEDICINE, INC. (US) | 2000-07-06 | — | — | WO | disclosed |